SCHEMBL25344309

SCHEMBL25344309

CN(CCN(CCO[Si](C)(C)C(C)(C)C)C(=O)OCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.41
CCR6 P51684 1/20 0.40
PAX8 Q06710 1/20 0.40
GBA1 P04062 1/20 0.39
HTR2C P28335 2/20 0.37
SLC6A4 P31645 2/20 0.37
F13A1 P00488 1/20 0.36
TGM2 P21980 1/20 0.36
TGM1 P22735 1/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC3 O15379 1/20 0.35
HDAC2 Q92769 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
GLS O94925 1/20 0.35
SYK P43405 1/20 0.35
POLB P06746 1/20 0.35
PDK2 Q15119 1/20 0.35
ALDH1A1 P00352 1/20 0.35
BTN3A1 O00481 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30510994 0.96 L3MBTL1 (0.41) L3MBTL1CCR6PAX8GBA1HTR2C
SCHEMBL25346091 0.90 CCR6 (0.42) L3MBTL1CCR6PAX8F13A1TGM2
SCHEMBL31447906 0.89 CCR6 (0.48) L3MBTL1CCR6PAX8ALDH1A1BTN3A1
SCHEMBL25977140 0.85 GBA1 (0.40) L3MBTL1GBA1HTR2CSLC6A4GLS
SCHEMBL7270408 0.85 CCR6 (0.47) L3MBTL1CCR6PAX8ALDH1A1BTN3A1
SCHEMBL30311467 0.83 CCR6 (0.48) L3MBTL1CCR6PAX8GBA1HTR2C
SCHEMBL25970374 0.83 CCR6 (0.45) L3MBTL1CCR6PAX8GBA1HTR2C
SCHEMBL19700749 0.82 L3MBTL1 (0.45) L3MBTL1CCR6PAX8GBA1HTR2C
SCHEMBL7775544 0.82 L3MBTL1 (0.50) L3MBTL1CCR6PAX8GBA1HTR2C
SCHEMBL1896284 0.81 ALDH1A1 (0.40) L3MBTL1CCR6PAX8F13A1TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257396-A1 MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS INC (US) 2023-08-17 US disclosed
EP-4178958-A1 MACROCYCLES AND THEIR USE Blossomhill Therapeutics, Inc. (US) 2023-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257396-A1 MACROCYCLES AND THEIR USE VHL, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DLD L3MBTL1 3134/4885CCR6 927/4885PAX8 4840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.